Evidence map›Paper›PMID 42351902›Full record

ArticleBioengineering (Basel, Switzerland)2026

Explainable Breast Cancer Detection Using Hierarchical Multi-Scale and Edge-Aware Transformer Networks.

Maria Altaib Badawi, Ehtisham Arshad, Armughan Ali, Oumaima Saidani, Taoufik Saidani, Zepa Yang, Yunyoung Nam

Abstract read
In one paragraph

Article in Bioengineering (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Maria Altaib BadawiDepartment of Computer Science and Information, College of Science Zulfi, Majmaah University, Al-Majmaah 11952, Saudi Arabia.ORCID 0000-0002-1858-7394
Ehtisham ArshadDepartment of Software Engineering, Faculty of Computing, Blekinge Institute of Technology, 371 79 Karlskrona, Sweden.
Armughan AliDepartment of Computer Science, University of Wah, Wah Cantt 47040, Pakistan.ORCID 0009-0009-9930-6053
Oumaima SaidaniDepartment of Information Systems, College of Computer and Information Sciences, Princess Nourah Bint Abdulrahman University, P.O. Box 84428, Riyadh 11671, Saudi Arabia.ORCID 0000-0001-9520-3174
Taoufik SaidaniCenter for Scientific Research and Entrepreneurship, Northern Border University, Arar 73213, Saudi Arabia.
Zepa YangDepartment of Computer Science and Engineering, Soonchunhyang University, Asan 31538, Republic of Korea.
Yunyoung NamDepartment of Computer Science and Engineering, Soonchunhyang University, Asan 31538, Republic of Korea.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Breast cancer remains the leading cause of cancer-related deaths among women globally. Early detection through mammography is vital for improving survival rates; however, the large volume of medical images and subtle variations in lesion characteristics pose significant challenges to manual interpretation. Recent automated diagnostic models based on deep learning have shown strong potential for breast cancer classification, but challenges such as overfitting, high computational complexity, limited generalization, and insufficient interpretability remain unresolved. This paper proposes a computationally efficient and context-aware deep learning framework for breast cancer classification using transformer-based multi-scale attention mechanisms and explainable artificial intelligence (XAI). The proposed architecture integrates the Hierarchical Multi-Scale Transformer (HMT) and Edge-Aware Local Transformer (ELT) modules to jointly capture global contextual dependencies and boundary-sensitive local representations from mammographic images. ELT improves feature refinement in high-entropy regions, while HMT models global semantic interactions across multiple feature scales. In addition, an Adaptive Contextual Refinement (ACR) module is introduced to preserve semantically consistent feature representations across spatial resolutions. A Meta-Ensemble Classification (MEC) framework combining weighted SVM and K-Nearest Neighbors (KNN) classifiers is further employed using validation-guided class-adaptive weighting. The proposed framework is evaluated on four benchmark mammography datasets, namely CBIS-DDSM, DDSM, INBreast, and MIAS. The proposed model has demonstrated superior accuracy of over 99% across all breast cancer datasets. The model surpassed transformer-based baselines including Swin-T and ViT while maintaining lower parameter complexity and achieving approximately 7% higher accuracy on the CBIS-DDSM dataset. The proposed framework also demonstrated strong cross-dataset generalization and consistently achieved high precision, recall, and F1-score values across all benchmark datasets. To improve model interpretability, Grad-CAM, SHAP, Occlusion Sensitivity Analysis (OSA), and the proposed TIxAI consistency analysis framework are incorporated to provide preliminary explainability assessment for mammographic classification. The explainability analysis demonstrated spatially consistent saliency behavior across benchmark datasets; however, the current evaluation is based on internal saliency consistency rather than external clinical validation using expert lesion annotations. Overall, the proposed framework provides an effective and computationally efficient approach for automated breast cancer classification while improving model explainability and interpretability.

Indexed as

breast cancer diagnosisdeep learningEdge-Aware Local Transformer (ELT)Explainable AI (XAI)Hierarchical Multi-Scale Transformer (HMT)mammographyMeta-Ensemble Classification (MEC)model generalization

Identifiers

PMID42351902
PMCPMC13295932

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.